Back to basics and reality30 May 2022 17:22
After reading numerous posts on here....often conflicting, I thought I’d AIM (get it! (Dad joke sorry)) to get some realistic balance on here.
Plenty of negative stance - not needed
Plenty of BS ramping - not needed
Plenty of rumour creating - not needed
........ but, this is what we have.
The following, I believe, is relatively where we are and where we could be
....
Just received CTDA approval giving us access to the UK market and ability to sell across the board with our “best of it’s kind” Covid kit
.
Already got CE approval on the same for selling across Europe.
.
We are now potentially in fresh waters regarding the UK so time will tell if there is still a market hungry enough for our kit, from individual to bulk and wholesale, direct and indirect.
.
Admittedly we are all left elusive at present with regards to sales, if any or not. If any, how many and if we have any “orders” in the making. Please note, that an agreed contract (as in agreed sales) might not mean we get an automatic RNS or even a considered one. This also does not mean, that it’s negative..... it’s just currently UNKNOWN.
.
We all, I believe, are pretty much aware of our status regarding AIHL and from how I currently see it is that we are sitting tight on some eagerly awaited updates on how the NHS plans are progressing.
.
Regarding AIHL and the NHS, it was mentioned a few weeks ago (when we had the awesome news) that roll out would be in the coming weeks, so further, updated news must now be imminent.
.
The potential as many would agree is ENORMOUS for AIHL roll out. In time of course but this could pave the way for worldwide normality in due process.
Not only for AIHL specifically, but this medical wonder of analysing genomes and their behaviour opens the door to many other paths in the medical world.... this is what I see to be as the GOLDEN GOOSE for Genedrive.
.
This then leads, once we’ve realised what we have and where it could take us to the “rumoured” aspects of some rampers. We do not, as far as we know it, have ANY evidence of potential buyouts/takeovers.
.
But here’s the elephant in the room..... we are massively primed for a large pharma to have keen interest in us.
.
It’s not about sales and if we have sales that makes us attractive.... not in the medical world
.
What makes us extremely attractive as a potential buyout is our potential and also as a threat.
.
Our potential could make us a household name in the medical world.
.
Our threat is that we could take away massive business potential from larger pharma. So the idea of a buyout in this instance is to step on it before it gets bigger.
.
I’ve had this happen to me.... worked in a small company that thrived on something with a fresh take, after about 3 years we had an offer made too good to ignore.... after buyout, then a year later they quashed the small company and blended it with the bigger. Small company now a forgotten name.
I hope much of above overall ma
Sign In
Follow the stocks
